Global institutions warned Mexico about the dangers of poor public policy and investment, the World Bank said that low investment in healthcare led to lower productivity and the WHO called for better urban planning to reduce sedentarism and obesity. Furthermore, the country is experiencing a rise in diabetic retinopathy. In brighter news, Michoacan researchers won a grant for their study on the relationship between microbiota and stress.
This Wednesday the world celebrated International Mental Health Day to increase awareness of the dangers of depression, suicide and many other diseases. Roche invested in the development drug to treat common cause of blindness, scientist warned of a rise in C-sections and same-sex mice reproduced with the help of CRISP.
The Federal Commissioner of COFEPRIS, Julio Sanchez y Tépoz, spoke to Mexico Health Review on the institution’s main achievements during the last six years, of which the council’s generics policies standout for increasing access to medicines.
Now, jump in last week’s highlights:
Poor investment in education and healthcare has led Mexico to lose 40 percent of its productivity: World Bank.
During the Global Climate Action Summit, WHO specialist called for better urban planning in Mexico to reduce the use of cars in large cities and tackle both sedentarism and climate change.
Biocodex Microbiota Foundation (BMF) awarded researchers from IMSS’ Biomedical Research Center of Michoacan for their study on whether bacterial recolonization of rats’ guts can revert the effects of stress.
Doctor from the International Agency for the Prevention of Blindness warned that only 50 percent of diabetics at risk of diabetic retinopathy visit an ophthalmologist. This disease has increased by 25 percent in diabetics and, untreated, can lead to blindness.
Scientists warn about overuse of unnecessary cesarean sections, which has nearly doubled in 15 years.
Chinese researchers use CRISP-modified cells to help mice of the same sex reproduce. Mice born from two female mice grew into adulthood and reproduced on their own to have healthy pups.
Roche signs US$75 million check for Ionis for the development of treatment for dry macular degeneration (AMD), a common cause of vision loss among people over 65.